Kevin S King1, Julia Kozlitina2, Roger N Rosenberg3, Ronald M Peshock1, Roderick W McColl1, Christine K Garcia2. 1. Department of Radiology, University of Texas Southwestern Medical Center, Dallas. 2. Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas3Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas. 3. Department of Neurology, University of Texas Southwestern Medical Center, Dallas5Editor, JAMA Neurology.
Abstract
IMPORTANCE: Telomere length has been associated with dementia and psychological stress, but its relationship with human brain size is unknown. OBJECTIVE: To determine if peripheral blood telomere length is associated with brain volume. DESIGN, SETTING, AND PARTICIPANTS: Peripheral blood leukocyte telomere length and brain volumes were measured for 1960 individuals in the Dallas Heart Study, a population-based, probability sample of Dallas County, Texas, residents, with a median (25th-75th percentile) age of 50 (42-58) years. Global and 48 regional brain volumes were assessed from the automated analysis of magnetic resonance imaging. MAIN OUTCOMES AND MEASURES: Telomere length and global and regional brain volumes. RESULTS: Leukocyte telomere length was associated with total cerebral volume (β [SE], 0.06 [0.01], P <.001) including white and cortical gray matter volume (β [SE], 0.04 [0.01], P = .002; β [SE], 0.07 [0.02], P <.001, respectively), independent of age, sex, ethnicity, and total intracranial volume. While age was associated with the size of most subsegmental regions of the cerebral cortex, telomere length was associated with certain subsegmental regions. Compared with age, telomere length (TL) explained a sizeable proportion of the variance in volume of the hippocampus, amygdala, and inferior temporal region (hippocampus: βTL [SE], 0.08 [0.02], R2, 0.91% vs βage [SE], -0.16 [0.02], R2, 3.80%; amygdala: βTL [SE], 0.08 [0.02], R2, 0.78% vs βage [SE],-0.19 [0.02], R2,4.63%; inferior temporal: βTL [SE], 0.07 [0.02], R2, 0.92% vs βage [SE], -0.14 [0.02], R2, 3.98%) (P <.001 for all). The association of telomere length and the size of the inferior and superior parietal, hippocampus, and fusiform regions was stronger in individuals older than 50 years than younger individuals (inferior parietal: β>50 [SE], 0.13 [0.03], P <.001 vs β≤50 [SE], 0.02 [0.02], P = .51, P for interaction = .001; superior parietal: β>50 [SE], 0.11 [0.03], P <.001 vs β≤50 [SE], 0.01 [0.02], P = .71, P for interaction = .004; hippocampus: β>50 [SE], 0.10 [0.03], P = .004 vs β≤50 [SE], 0.05 [0.02], P = .07, P for interaction = .04; fusiform: β>50 [SE], 0.09 [0.03], P = .002, β≤50 [SE], 0.03 [0.02], P = .31, P for interaction = .03). The volume of the hippocampus, amygdala, superior and inferior temporal, precuneus, lateral orbitofrontal, posterior cingulate, thalamus and ventral diencephalon were independently associated with telomere length after adjustment for all covariates (age, gender, ethnicity, total intracranial volume, body mass index, blood pressure, diabetes, smoking status, and APOE genotype). CONCLUSIONS AND RELEVANCE: To our knowledge, this is the first population-based study to date to evaluate telomere length as an independent predictor of global and regional brain size. Future studies are needed to determine how telomere length and anatomic structural changes are related to cognitive function, dementia, and psychological disease.
IMPORTANCE: Telomere length has been associated with dementia and psychological stress, but its relationship with human brain size is unknown. OBJECTIVE: To determine if peripheral blood telomere length is associated with brain volume. DESIGN, SETTING, AND PARTICIPANTS: Peripheral blood leukocyte telomere length and brain volumes were measured for 1960 individuals in the Dallas Heart Study, a population-based, probability sample of Dallas County, Texas, residents, with a median (25th-75th percentile) age of 50 (42-58) years. Global and 48 regional brain volumes were assessed from the automated analysis of magnetic resonance imaging. MAIN OUTCOMES AND MEASURES: Telomere length and global and regional brain volumes. RESULTS: Leukocyte telomere length was associated with total cerebral volume (β [SE], 0.06 [0.01], P <.001) including white and cortical gray matter volume (β [SE], 0.04 [0.01], P = .002; β [SE], 0.07 [0.02], P <.001, respectively), independent of age, sex, ethnicity, and total intracranial volume. While age was associated with the size of most subsegmental regions of the cerebral cortex, telomere length was associated with certain subsegmental regions. Compared with age, telomere length (TL) explained a sizeable proportion of the variance in volume of the hippocampus, amygdala, and inferior temporal region (hippocampus: βTL [SE], 0.08 [0.02], R2, 0.91% vs βage [SE], -0.16 [0.02], R2, 3.80%; amygdala: βTL [SE], 0.08 [0.02], R2, 0.78% vs βage [SE],-0.19 [0.02], R2,4.63%; inferior temporal: βTL [SE], 0.07 [0.02], R2, 0.92% vs βage [SE], -0.14 [0.02], R2, 3.98%) (P <.001 for all). The association of telomere length and the size of the inferior and superior parietal, hippocampus, and fusiform regions was stronger in individuals older than 50 years than younger individuals (inferior parietal: β>50 [SE], 0.13 [0.03], P <.001 vs β≤50 [SE], 0.02 [0.02], P = .51, P for interaction = .001; superior parietal: β>50 [SE], 0.11 [0.03], P <.001 vs β≤50 [SE], 0.01 [0.02], P = .71, P for interaction = .004; hippocampus: β>50 [SE], 0.10 [0.03], P = .004 vs β≤50 [SE], 0.05 [0.02], P = .07, P for interaction = .04; fusiform: β>50 [SE], 0.09 [0.03], P = .002, β≤50 [SE], 0.03 [0.02], P = .31, P for interaction = .03). The volume of the hippocampus, amygdala, superior and inferior temporal, precuneus, lateral orbitofrontal, posterior cingulate, thalamus and ventral diencephalon were independently associated with telomere length after adjustment for all covariates (age, gender, ethnicity, total intracranial volume, body mass index, blood pressure, diabetes, smoking status, and APOE genotype). CONCLUSIONS AND RELEVANCE: To our knowledge, this is the first population-based study to date to evaluate telomere length as an independent predictor of global and regional brain size. Future studies are needed to determine how telomere length and anatomic structural changes are related to cognitive function, dementia, and psychological disease.
Authors: L A Panossian; V R Porter; H F Valenzuela; X Zhu; Erin Reback; D Masterman; J L Cummings; R B Effros Journal: Neurobiol Aging Date: 2003 Jan-Feb Impact factor: 4.673
Authors: Stefano Masi; Claire M Nightingale; Ian N M Day; Philip Guthrie; Ann Rumley; Gordon D O Lowe; Thomas von Zglinicki; Francesco D'Aiuto; Stefano Taddei; Nigel Klein; Klelia Salpea; Derek G Cook; Steve E Humphries; Peter H Whincup; John E Deanfield Journal: Arterioscler Thromb Vasc Biol Date: 2012-06-07 Impact factor: 8.311
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Cyrus A Raji; April J Ho; Neelroop N Parikshak; James T Becker; Oscar L Lopez; Lewis H Kuller; Xue Hua; Alex D Leow; Arthur W Toga; Paul M Thompson Journal: Hum Brain Mapp Date: 2010-03 Impact factor: 5.038
Authors: Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Melissa A Scheff; Elliott J Mufson Journal: J Alzheimers Dis Date: 2011 Impact factor: 4.472
Authors: G D Rabinovici; W W Seeley; E J Kim; M L Gorno-Tempini; K Rascovsky; T A Pagliaro; S C Allison; C Halabi; J H Kramer; J K Johnson; M W Weiner; M S Forman; J Q Trojanowski; S J Dearmond; B L Miller; H J Rosen Journal: Am J Alzheimers Dis Other Demen Date: 2007 Dec-2008 Jan Impact factor: 2.035
Authors: Aoife O'Donovan; Matthew S Pantell; Eli Puterman; Firdaus S Dhabhar; Elizabeth H Blackburn; Kristine Yaffe; Richard M Cawthon; Patricia L Opresko; Wen-Chi Hsueh; Suzanne Satterfield; Anne B Newman; Hilsa N Ayonayon; Susan M Rubin; Tamara B Harris; Elissa S Epel Journal: PLoS One Date: 2011-05-13 Impact factor: 3.240
Authors: Karl-Heinz Ladwig; Anne Catharina Brockhaus; Jens Baumert; Karoline Lukaschek; Rebecca T Emeny; Johannes Kruse; Veryan Codd; Sibylle Häfner; Eva Albrecht; Thomas Illig; Nilesh J Samani; H Erich Wichmann; Christian Gieger; Annette Peters Journal: PLoS One Date: 2013-07-03 Impact factor: 3.240
Authors: Adam M Staffaroni; Duygu Tosun; Jue Lin; Fanny M Elahi; Kaitlin B Casaletto; Matthew J Wynn; Nihar Patel; John Neuhaus; Samantha M Walters; Elissa S Epel; Elizabeth H Blackburn; Joel H Kramer Journal: Neurobiol Aging Date: 2018-05-08 Impact factor: 4.673
Authors: Daniel Lindqvist; Elissa S Epel; Synthia H Mellon; Brenda W Penninx; Dóra Révész; Josine E Verhoeven; Victor I Reus; Jue Lin; Laura Mahan; Christina M Hough; Rebecca Rosser; F Saverio Bersani; Elizabeth H Blackburn; Owen M Wolkowitz Journal: Neurosci Biobehav Rev Date: 2015-05-18 Impact factor: 8.989
Authors: Alessio Squassina; Mirko Manchia; Claudia Pisanu; Raffaella Ardau; Carlo Arzedi; Alberto Bocchetta; Paola Caria; Cristina Cocco; Donatella Congiu; Eleonora Cossu; Tinuccia Dettori; Daniela Virginia Frau; Mario Garzilli; Elias Manca; Anna Meloni; Maria Antonietta Montis; Andrea Mura; Mariella Nieddu; Barbara Noli; Pasquale Paribello; Federica Pinna; Renato Robledo; Giovanni Severino; Valeria Sogos; Maria Del Zompo; Gian Luca Ferri; Caterina Chillotti; Roberta Vanni; Bernardo Carpiniello Journal: Neuropsychopharmacology Date: 2020-09-12 Impact factor: 7.853
Authors: Diego A Forero; Yeimy González-Giraldo; Catalina López-Quintero; Luis J Castro-Vega; George E Barreto; George Perry Journal: J Gerontol A Biol Sci Med Sci Date: 2016-04-18 Impact factor: 6.053
Authors: Scott M Carlson; Julie Kim; David A Khan; Kevin King; Richard T Lucarelli; Roderick McColl; Ronald Peshock; E Sherwood Brown Journal: J Asthma Date: 2016-05-17 Impact factor: 2.515
Authors: Megan K Lowther; Jarrod P Tunnell; Jayme M Palka; Darlene R King; Damilola C Salako; Dimitri G Macris; Jay B Italiya; Justin L Grodin; Carol S North; E Sherwood Brown Journal: J Neuroimmunol Date: 2020-09-08 Impact factor: 3.478
Authors: Erika J Wolf; Mark W Logue; Jasmeet P Hayes; Naomi Sadeh; Steven A Schichman; Annjanette Stone; David H Salat; William Milberg; Regina McGlinchey; Mark W Miller Journal: Psychoneuroendocrinology Date: 2015-09-30 Impact factor: 4.905